
Results
2
2 companies
Hyloris Pharmaceuticals
Market Cap: €207.2m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€7.40
7D
-7.3%
1Y
37.0%
argenx
Market Cap: €42.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€695.60
7D
-1.2%
1Y
10.1%